NLRP3 and epilepsy: Similar experimental work in non-epilepsy models suggested that ketone body anti-inflammatory effects may be mediated by hydroxy-carboxylic acid receptor 2 (HCA2) and/or inhibition of the innate immune sensor NOD-like receptor 3 (NLRP3) inflammasome [23,43,44].